Dernièrement…

+70% pour @AmoebaNature alors que l'Agence américaine pour la protection de l'environnement a émis une pré-décision favorable après avoir évalué sa demande d'autorisation de 'Willaertia magna C2c Maky' https://www.boursorama.com/bourse/actualites/amoeba-vers-un-feu-vert-de-l-epa-pour-son-amibe-biocide-59c2a82b84038127133be13ae23167f9?symbol=1rPALMIB

$ALMIB #AMOEBA : L'US EPA en voie d’approuver le biocide d’Amoéba pour un usage dans les systèmes de refroidissement fermés https://t.news.calyptus.net/l2/7bPXwOEHO0/7007/2382335340.html?

📣 Communiqué de Presse : https://bit.ly/3zQlqqt
#Amoéba informe que l’US EPA a émis une pré-décision favorable pour commercialiser notre #biocide aux USA dans les systèmes de refroidissement fermés. Après 10 ans de #recherches, cette annonce légitime notre #savoirfaire unique💧

🏆 #Amoéba remporte l’Innovation Award
A l’occasion de la 3ème édition du #symposium @PBioprotech, les équipes d’Amoéba ont eu le plaisir de voir leur travail récompensé ! Un grand merci au jury pour avoir choisi notre #innovation #biocontrôle parmi les 11 candidats !

Uncategorized


10 August 2022

US EPA about to approve Amoéba’s biocide for use in closed cooling systems

Amoéba informs that the US EPA has made a positive pre-decisional determination for the use of Amoéba’s biocide in closed cooling systems.


13 June 2022

Amoéba : Issuance of the 5th tranche of OCA

Amoéba announces the issuance of the fifth tranche of 60 bonds convertible into shares as part of its new bond financing with incentive program with Nice & Green S.A.


30 May 2022

Amoéba: US regulatory calendar update

Amoeba announces that the US EPA, in charge of the evaluation of the biocide and biocontrol applications in the United States, has requested an extension of the assessment period : the conclusions should now be available in the second half of 2022.


6 May 2022

Ordinary and extraordinary general meeting to be held on 24 May 2022

Amoéba announces the availability of preparatory documents for the General Assembly of May 24, 2022


3 May 2022

Amoeba: Malta recommends the non-approval of the “biocide” active substance for the European territory

Amoeba announces that the Maltese authority recommends the non-approval of the biocidal active substance for the European territory


25 April 2022

Amoéba: Austria recommends the approval of the biocontrol application in Europe

Amoéba announces that AGES, in charge of the application for approval of the biocontrol active substance “Lysate of Willaertia magna C2c Maky”, recommends its approval for use in plant protection on the European territory.


13 April 2022

Amoéba : Publication of the 2021 Universal Registration Document

Amoéba announces that the 2021 Universal Registration Document was filed with the French Financial Markets Authority (Autorité des marchés financiers AMF) on April 12, 2022.


5 April 2022

Amoéba : Deferral of the 5th tranche of OCAs

Amoéba announces having exercised the suspension option relating to the issuance of the 5th tranche of OCAs, initially scheduled for April 5, 2022.


25 March 2022

Update of the European regulatory application calendar

Amoéba announces a report of the conclusion of the evaluation of the European biocide and biocontrol dossiers.


24 August 2021

Results of the 2nd cereal trial campaign

Amoeba confirms its biocontrol’s effectiveness against major cereal diseases


29 July 2021

Promising results of the Biocontrol-Grapewine application

Amoéba announces the results of the field trials 3rd campaign on grapes


5 July 2021

Postponement of the biocide active substance dossier

Malta commits to finalize the report in the 4th quarter of 2021


24 June 2021

Appointment of Philippe Dujardin to the Board of Directors

Philippe Dujardin replaces Pascal Reber as independent director


2 June 2021

General Meeting of June 24, 2021

Availability of the preparatory documents for the General meeting of 27 may 2021


27 May 2021

General Meeting second convocation

Due to a lack of quorum, the General Meeting is postponed to June 24, 2021


10 May 2021

General Assembly of May 27, 2021

Amoéba provides shareholders with preparatory documents


6 April 2021

Submission of the biocide application in the USA

Amoéba has submitted the application for approval of the biocidal active substance


6 April 2021

Massive new field trials campaign

Amoeba continues testing its biocontrol product in 2021


26 March 2021

Amoéba announces the 2020 financial year results

marked by the continued development of its biocidal and biocontrol applications


12 March 2021

Research partnership with the US group GOWAN COMPANY

Amoéba extends to the U.S.A. the testing of its biocontrol


10 March 2021

Appointment of Pierre Morgon to the Board of Directors

Amoéba has appointed Pierre Morgon as censor.


10 March 2021

Development and commercialization agreement

Signature of a Letter of Intent (LOI) with PHILAGRO France


18 December 2020

Signature of a non-exclusive development and marketing agreement

in Switzerland with Stähler for its vine Bioncontrol product.